Darya Khantakova

6PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersAutoimmunityTumour immunologyHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 11, 2026
Bone-derived Osterix+ osteolineage cells are a source of tumor-promoting myofibroblastic cancer-associated fibroblasts in breast cancer.

|Mar 05, 2026
Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy.

Yun Chen, Yizhou Liu, Khai Nguyen

|Sep 23, 2024
At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable Targets.

Eleonora Timperi, Hugo Croizer, Darya Khantakova

|Jul 24, 2024
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy.

Hussein Sultan, Yoshiko Takeuchi, Jeffrey P Ward

|May 17, 2024
TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti-PD-1 tumor immunotherapy.

Blanda Di Luccia, Martina Molgora, Darya Khantakova

|Jun 24, 2022
Exploring the Impact of TREM2 in Tumor-Associated Macrophages.

Darya Khantakova, Simone Brioschi, Martina Molgora

Pageof 1

Frequent Collaborators

4 joint publications

Marco Colonna

3 joint publications

Martina Molgora

2 joint publications

Maxim N Artyomov

2 joint publications

Patrick F Rodrigues